Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

On CNBC's “Mad Money Lightning Round,” Jim Cramer said MicroStrategy Incorporated (NASDAQ:MSTR) is a Bitcoin play and he prefers to actually own Bitcoin (CRYPTO: BTC).

MicroStrategy announced it completed its previously announced offering of its 0% convertible senior notes due 2029. MicroStrategy said the aggregate principal amount of the notes sold in the offering was $3 billion, which includes $400 million aggregate principal amount of notes issued pursuant to an option to purchase.

When asked about Oscar Health, Inc. (NYSE:OSCR), he said, “Until I saw that Mark Bertolini is the CEO, I didn't really have much in store for this. But Bertolini's a winner and a hitter.”

Don’t Miss:

• Coinbase’s latest promo gets you $50 in free bitcoin (Seriously!) — Here's everything you need to know to take advantage of this offer.

• Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O’Reilly and Rudy Giuliani are using this platform to create customized gold IRAs to help shield their savings from inflation and economic turbulence.

On Nov. 7, Oscar Health reported a quarterly loss of 22 cents per share which missed the analyst consensus estimate of a loss of 19 cents per share. The company reported quarterly sales of $2.42 billion which beat the analyst consensus estimate of $2.34 billion.

CNH Industrial N.V. (NYSE:CNH) is a “second-rater,” Cramer said. “I want to go with best of breed, and best of breed is John Deere (NYSE:DE).”

On Nov. 7, CNH Industrial reported worse-than-expected third-quarter EPS results and also lowered FY24 adjusted EPS outlook.

“The former, BGS, is a total loser and has been a loser for many, many years,” Cramer said when asked about B&G Foods, Inc. (NYSE:BGS).

On Nov. 5, B&G Foods reported worse-than-expected third-quarter financial results and issued FY24 net sales guidance below estimates.

When asked about Rocket Lab USA, Inc. (NASDAQ:RKLB), he said, “It's moth to flame, but I don't know how close the moth is to the flame.”

On Nov. 19, Goldman Sachs analyst Noah Poponak maintained Rocket Lab with a Neutral and raised the price target from $5 to $12.

Price Action:

• Oscar Health shares fell 4.1% to settle at $16.31 on Thursday.

• CNH Industrial shares gained 4.6% to close at $11.92.

• Rocket Lab shares gained 11.1% to close at $22.41.

• MicroStrategy shares fell 16.2% to settle at $397.28 during the session.

Check It Out:

EquityMultiple's ‘Alpine Note — Basecamp Series' is turning heads and opening wallets. This short-term note investment offers investors a 9% rate of return (APY) with just a 3 month term and $5K minimum. The Basecamp rate is at a significant spread to t-bills. This healthy rate of return won't last long. With the Fed poised to cut interest rates in the near future, now could be the time to lock in a favorable rate of return with a flexible, relatively liquid investment option.